Kerry D. Ingalls - Mar 16, 2022 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Stock symbol
PSTX
Transactions as of
Mar 16, 2022
Transactions value $
$11,940
Form type
4
Date filed
3/18/2022, 08:01 PM
Previous filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Purchase $11.9K +3K +5.77% $3.98 55K Mar 16, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.965 to $3.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.